Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
Revista De Neurologia
|
November 29, 2018
[«Apuntes en Neurologia» (Notes in Neurology): a synthesis of the evidence on common paroxysmal neurological disorders and on neurodegenerative disorders]
M Toledo, C Carnero-Pardo, M Carreno-Martinez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2019
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens
Gerald P Linette, Michelle Becker-Hapak, Zachary L Skidmore, et al.
Nature Communications
|
July 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Adham S Bear, Tatiana Blanchard, Joseph Cesare, et al.
The Journal of Clinical Investigation
|
September 17, 2024
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Adham S Bear, Rebecca B Nadler, Mark H O'Hara, et al.
Nature Immunology
|
February 27, 2001
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Y Latchman, C R Wood, T Chernova, et al.
Blood Advances
|
April 7, 2026
HLA-E single-chain trimer shields gene-edited allogeneic CAR T Cells from NK cell attack
Gerald P Linette, Kimberly Apodaca, Chong Xu, et al.
Genome Medicine
|
April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Lijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Cancer Cell
|
December 13, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
Anže Smole, Alexander Benton, Mathilde A Poussin, et al.
Blood
|
June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Cancer Cell
|
February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
Revista De Neurologia
|
November 29, 2018
[«Apuntes en Neurologia» (Notes in Neurology): a synthesis of the evidence on common paroxysmal neurological disorders and on neurodegenerative disorders]
M Toledo, C Carnero-Pardo, M Carreno-Martinez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2019
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens
Gerald P Linette, Michelle Becker-Hapak, Zachary L Skidmore, et al.
Nature Communications
|
July 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Adham S Bear, Tatiana Blanchard, Joseph Cesare, et al.
The Journal of Clinical Investigation
|
September 17, 2024
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Adham S Bear, Rebecca B Nadler, Mark H O'Hara, et al.
Nature Immunology
|
February 27, 2001
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Y Latchman, C R Wood, T Chernova, et al.
Blood Advances
|
April 7, 2026
HLA-E single-chain trimer shields gene-edited allogeneic CAR T Cells from NK cell attack
Gerald P Linette, Kimberly Apodaca, Chong Xu, et al.
Genome Medicine
|
April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Lijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Cancer Cell
|
December 13, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety
Anže Smole, Alexander Benton, Mathilde A Poussin, et al.
Blood
|
June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Cancer Cell
|
February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
Patrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Page
of 14